Zobrazeno 1 - 10
of 40
pro vyhledávání: '"M. I. Sekacheva"'
Publikováno v:
Issledovaniâ i Praktika v Medicine, Vol 10, Iss 4, Pp 48-58 (2023)
Purpose of the study. Сomparing and evaluating the prognostic potential of the CORONET online risk assessment tool and the Charlson Comorbidity Index in predicting mortality in cancer patients with COVID-19.Materials and methods. The results are dra
Externí odkaz:
https://doaj.org/article/1e6bac4ca7fd44db9f89f5d5860becb8
Autor:
Zh. R. Cherkasova, S. A. Tsurkan, A. I. Prostyakova, A. M. Boroda, A. A. Rozhkov, Yu. N. Pirogova, N. M. Nikitina, M. I. Sekacheva
Publikováno v:
Issledovaniâ i Praktika v Medicine, Vol 10, Iss 1, Pp 10-26 (2023)
Purpose of the study. Evaluation of the diagnostic characteristics of the CA‑62 marker for epithelial carcinomas for detecting early‑stage prostate cancer in a double‑blind clinical study. This study is also focused on the possibility of using
Externí odkaz:
https://doaj.org/article/e65cce7e8fe042ce860d1fea18e067e9
Autor:
E. V. Artamonova, V. V. Breder, L. Yu. Vladimirova, I. A. Demidova, E. N. Imyanitov, К. К. Laktionov, M. P. Matrosova, S. V. Orlov, E. О. Rodionov, D. D. Sakaeva, M. I. Sekacheva, A. V. Smolin, N. V. Fadeeva, M. L. Filipenko
Publikováno v:
Медицинский совет, Vol 0, Iss 9, Pp 50-56 (2022)
The Advisory Board was held on December 24, 2021. The molecular genetic research lead specialists and national lead oncologists discussed issues of diagnosis of NTRK gene translocations in patients with non-small cell lung cancer (NSCLC), as well as
Externí odkaz:
https://doaj.org/article/186fbc488e5c4c5dbd4fa32b6b40705e
Autor:
Z. Z.A. Fashafsha, P. Sh. Chomakhidze, D. F. Mesitskaya, A. Yu. Suvorov, M. I. Sekacheva, E. V. Poddubskaya, E. S. Tyukanova, M. V. Sankova, M. A. Ozova, V. D. Levina, D. А. Andreev, F. Yu. Kopylov
Publikováno v:
Российский кардиологический журнал, Vol 27, Iss 11 (2022)
Aim. To evaluate the early manifestation of cardiotoxicity after the first course of multiagent chemotherapy (MAC) using echocardiography with an assessment of the left ventricular ejection fraction (LVEF) and global longitudinal strain (GLS).Materia
Externí odkaz:
https://doaj.org/article/569fb9aa9b164e0a8a9d656d51859cca
Autor:
M. I. Sekacheva, A. S. Rusanov, A. S. Fatyanova, A. M. Boroda, A. L. Istranov, S. N. Rusanov, Yu. V. Babayeva, E. V. Poddubskaya
Publikováno v:
Сеченовский вестник, Vol 11, Iss 2, Pp 62-73 (2020)
Novel coronavirus infection, causing COVID-19, is not fully controlled for today. In periodicals, there are often reports of a high risk of severe complications in cancer patients during the development of COVID-19. The review presents information fr
Externí odkaz:
https://doaj.org/article/ac1c9de42a2747b7baf3468777b53e44
Publikováno v:
Современная онкология, Vol 22, Iss 3, Pp 109-113 (2020)
Over the past two decades, many new variants of targeted therapy for metastatic colorectal cancer (mCRC) had appeared, and significantly increased patient survival. However, there were questions relating to the definition of the optimal sequence and
Externí odkaz:
https://doaj.org/article/5e4f261f79964feabb01d7d3d9dc1d9c
Publikováno v:
Сеченовский вестник, Vol 10, Iss 4, Pp 4-11 (2019)
Immune checkpoint inhibitors (ICPIs) agents can cause endocrine immune-related adverse events (irAEs).Aim. Determine the incidence, time of onset and risk factors of endocrine irAEs in cancer patients treated with anti-PD1 and anti-CTLA-4 immunothera
Externí odkaz:
https://doaj.org/article/45fe04f53d1a4f228010fda67b633300
Publikováno v:
Issues of Reconstructive and Plastic Surgery. 25:15-28
Purpose of the study: a comparison of various vaginoplasty techniques and results in patients with transsexualism based on the analysis of data from the world scientific literature.Material and methods. The seeking of published research results place
Autor:
M I Sekacheva, N N Bagmet
Publikováno v:
Современная онкология, Vol 18, Iss 3, Pp 43-47 (2016)
The problem of the treatment of metastatic colorectal cancer makes us to continue for seeking new ways of severe disease treatment. Regorafenib is the newest drug for use in patients who have received all possible variants of therapy. The efficacy an
Externí odkaz:
https://doaj.org/article/aa2af41e1ce24598bbc355618fa9908c
Autor:
O G Skipenko, D A Chekunov, G A Shatverian, N N Bagmet, M I Sekacheva, R S Polyakov, A L Bedzhanyan, A G Abdullaev, Ya G Moysyuk
Publikováno v:
Современная онкология, Vol 17, Iss 3, Pp 61-69 (2015)
Background. Hepatocellular carcinoma (HCC) is a malignancy of the liver associated with poor prognosis. The understanding of the prevalence of liver damage and functional status of the liver can complicate therapy in these patients and often requires
Externí odkaz:
https://doaj.org/article/24f0e2cea78d418aa0b7accb804a5108